Pharmafile Logo
Pharmafocus logo
Advanced Search

MSD

Showing 15 posts of 247 posts found.

astrazeneca_logo_building

AZ and MSD secure three bits of good news on key drug

August 18, 2017
Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical

It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …

News

MSD CEO sparks exodus from Trump’s manufacturing council over Charlottesville violence

August 15, 2017
Manufacturing and Production MSD, Merck, Prsident's American Manufacturing Council, charlottesville, pharma, pharmaceuticals

In a shock move, MSD Chairman and Chief Executive Officer Kenneth Frazier (pictured) has announced that he is to resign …

News
injection-2248377_960_720

Global shortage of hep B vaccine hits UK

August 9, 2017
Manufacturing and Production, Research and Development GSK, MSD, biotech, drugs, hep b, hepatitis B, pharma, pharmaceutical

Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …

News
shire_austria_facility

Shire shifts vaccine facility from Baxalta deal to MSD

August 8, 2017
Manufacturing and Production Baxalta, MSD, Shire, biotech, drugs, pharma, pharmaceutical

As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven …

News

AZ attempts to clear dust of Mystic trial with $8.5 billion MSD deal

July 27, 2017
Medical Communications, Sales and Marketing AstraZeneca, MSD, Merck, biotech, drugs, immunotherapy, mystic, pharma, pharmaceutical

It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …

News
merck_and_co

MSD’s Keytruda hits rare snag, floundering in confirmatory trial

July 25, 2017
Manufacturing and Production, Sales and Marketing MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical

Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …

News
merck_and_co

MSD’s Lantus biosimilar given conditional FDA approval

July 21, 2017
Medical Communications, Sales and Marketing FDA, MSD, Sanofi, biosimilar, biotech, drugs, pharma, pharmaceutical

MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, …

News
merck_entrance

FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017
Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

News
hack

MSD struck in second global cyber attack

June 28, 2017
Medical Communications, Research and Development Cyber attack, MSD

Following the recent and heavily-publicised ransomware attack which hit the NHS in the UK and almost 100 other countries, the …

News
220399586_ec18abd879_z

MSD allays Irish fears with €280m expansion investment

May 31, 2017
Manufacturing and Production, Research and Development Ireland, MSD

There were fears in Ireland that President Trump’s strong words to bring manufacturing back to the US would hurt the …

News
keytruda3-web

MSD receives first FDA approval based on specific genetic feature

May 24, 2017
Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda

In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …

News
merckincweb1

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017
Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …

News
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017
Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …

News
merck_and_co

MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma

March 15, 2017
Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda

MSD, otherwise known as Merck in North America, continues to score indication successes with Keytruda, this time in Hodgkin lymphoma. …

News
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025